FDA and Biotech
MIRM: FDA Approves ATEBRIOZ on November 3
The local catalyst feed records an FDA approval for Mirum's ATEBRIOZ and orphan drug designation for brelovitug on November 3. The entries concern separate drugs and indications.
CATEGORY
FDA and Biotech